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Parkinson’s disease (PD) is a neurodegenerative disease associated with progressive
and inexorable loss of dopaminergic cells in Substantia Nigra pars compacta (SNc).
Although many mechanisms have been suggested, a decisive root cause of this cell
loss is unknown. A couple of the proposed mechanisms, however, show potential for
the development of a novel line of PD therapeutics. One of these mechanisms is the
peculiar metabolic vulnerability of SNc cells compared to other dopaminergic clusters;
the other is the SubThalamic Nucleus (STN)-induced excitotoxicity in SNc. To investigate
the latter hypothesis computationally, we developed a spiking neuron network-model of
SNc-STN-GPe system. In the model, prolonged stimulation of SNc cells by an overactive
STN leads to an increase in ‘stress’ variable; when the stress in a SNc neuron exceeds a
stress threshold, the neuron dies. Themodel shows that the interaction between SNc and
STN involves a positive-feedback due to which, an initial loss of SNc cells that crosses
a threshold causes a runaway-effect, leading to an inexorable loss of SNc cells, strongly
resembling the process of neurodegeneration. Themodel further suggests a link between
the two aforementioned mechanisms of SNc cell loss. Our simulation results show that
the excitotoxic cause of SNc cell loss might initiate by weak-excitotoxicity mediated
by energy deficit, followed by strong-excitotoxicity, mediated by a disinhibited STN. A
variety of conventional therapies were simulated to test their efficacy in slowing down SNc
cell loss. Among them, glutamate inhibition, dopamine restoration, subthalamotomy and
deep brain stimulation showed superior neuroprotective-effects in the proposed model.
Keywords: Parkinson’s disease, excitotoxicity, deep brain stimulation, Izhikevich neuron model, Substantia Nigra
pars compacta, SubThalamic Nucleus, Globus Pallidus externa, metabolic disorders
1. INTRODUCTION
There is a long tradition of investigation into the etiology and pathogenesis of Parkinson’s Disease
(PD) that seeks to link molecular (pesticides, oxidative stress, protein dysfunction etc.) (Hwang,
2013; Ortiz et al., 2016; Chiti and Dobson, 2017; Anselmi et al., 2018; Stykel et al., 2018) and
subcellular (mitochondrial dysfunction etc.) (Henchcliffe and Beal, 2008; Reeve et al., 2018; Tsai
et al., 2018) factors with the disease development. However, recent years see the emergence of two
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novel lines of investigation into PD pathogenesis. These
approaches, that aim to understand the PD pathology
at the cellular and network level, mark a significant
deviation from the traditional approaches (Rodriguez
et al., 1998; Pissadaki and Bolam, 2013; Pacelli et al., 2015;
Chakravarthy and Moustafa, 2018).
The first approach believes the primary factor that causes the
degeneration of dopaminergic neurons of Substantia Nigra pars
compacta (SNc) is its high metabolic requirements. SNc neurons
are one of the most vulnerable and energy consuming neuronal
clusters, due to their structural and functional properties. Here,
we have listed down some of the plausible factors which make
SNc cells to be most susceptible.
• Complex axonal arbors: Large axonal arborisation
which requires large amounts of energy to drive
currents along these axons (Bolam and Pissadaki, 2012;
Pissadaki and Bolam, 2013).
• Reactive neurotransmitter: When a reactive neurotransmitter
like dopamine is present in excess, it would readily oxidizes
with proteins, nucleic acids and lipids (Sulzer, 2007) eventually
leading to neurodegeneration. One of the mechanisms for
sequestration of excess cytosolic dopamine is packing of
dopamine into synaptic vesicles through vesicular monoamine
transporter-2 (VMAT-2) using H+ concentration gradient
which is maintained by H+-ATPase. In addition to that, in
the case of substantia nigra, the expression of VMAT2 is lower
than in the ventral tegmental area (Liang et al., 2004;Mosharov
et al., 2009) which likely causes dopamine-mediated oxidative
stress in SNc cells.
• Auto-rhythmicity: Uses L-type calcium channels for
maintaining the pace-making type of firing which in
turn requires higher amounts of energy to maintain calcium
homeostasis (Surmeier et al., 2017) and lower expression of
calcium-binding proteins (lower capacity of calcium buffering
mechanism) adds additional burden on the cell’s metabolic
activity (German et al., 1992).
• NMDA synaptic activation: Due to pacemaker type of firing,
magnesium blockage of NMDA receptors is ineffective,
resulting in substantial NMDA receptor currents even with
weak glutamatergic inputs resulting in additional burden
to maintain calcium homeostasis; the resulting energy
deficiency leads to excitotoxicity (Rodriguez et al., 1998;
Surmeier et al., 2010).
• Prone to neuroinflammation: Astrocytes play a modulatory
role in microglial activation (McGeer andMcGeer, 2008; Glass
et al., 2010; Rocha et al., 2012) and any miscommunication
between them results in neuroinflammation which eventually
leads to neurodegeneration (Waak et al., 2009; Booth et al.,
2017). The risk of inflammation in SNc neurons is high
due to the small proportion of astrocytes regulating the
huge population of microglia in this region (Lawson et al.,
1990; Whitton, 2007; Mena and García de Yébenes, 2008). It
has been reported that neuromelanin can induce microglial
activation (Zecca et al., 2008; Zhang et al., 2011). SNc neurons
are more susceptible to neuro-melanin induced inflammation
compared to VTA neurons due to their high neuro-melanin
biosynthesis as a result of underexpression of VMAT2 (Peter
et al., 1995; Liang et al., 2004).
• Weak microvasculature: SNc neurons are more prone to
environmental toxins due to weak surrounding cerebral
microvasculature (Rite et al., 2007).
Since the metabolic demands of SNc neurons are particularly
high when compared to any other neuronal types (Sulzer,
2007) including neurons of other dopaminergic systems (Bolam
and Pissadaki, 2012; Pacelli et al., 2015; Giguère et al.,
2018), any sustained insufficiency in the supply of energy
can result in cellular degeneration, characteristic of PD
(Mergenthaler et al., 2013).
According to the second approach, the overactivity of
SubThlamic Nucleus (STN) in PD causes excessive release of
glutamate to the SNc, which in turns causes degeneration
of SNc neurons by glutamate excitotoxicity (Rodriguez et al.,
1998). The above two approaches are interrelated and not
entirely independent as one form of excitotoxicity - the ‘weak
excitotoxicity’ - is thought to have its roots in impaired cellular
metabolism (Albin and Greenamyre, 1992). Therefore, the
insight behind these new lines of investigation is the mismatch
in energy supply and demand which could be a primary factor
underlying neurodegeneration in PD. Such a mismatch is more
likely to take place in special nuclei like SNc due to their peculiar
metabolic vulnerability (Bolam and Pissadaki, 2012; Pissadaki
and Bolam, 2013; Sulzer and Surmeier, 2013; Pacelli et al., 2015;
Surmeier et al., 2017; Giguère et al., 2018). Similar ideas have
been proffered to account for other forms of neurodegenerative
diseases such as Huntington’s disease, Alzheimer’s disease, and
amyotrophic lateral sclerosis (Beal et al., 1993; Johri and Beal,
2012; Gao et al., 2017).
If metabolic factors are indeed the underlying reason behind
PD pathogenesis, it is a hypothesis that deserves closer attention
and merits a substantial investment of time and effort for an
in-depth study. This is because any positive proof regarding
the role of metabolic factors puts an entirely new spin on
PD research. Several researchers proposed that systems-level
energy imbalance probably a principal cause of PD (Wellstead
and Cloutier, 2011; Bolam and Pissadaki, 2012; Pacelli et al.,
2015). Unlike current therapeutic approaches that manage the
symptoms rather than provide a cure, the new approach can in
principle point to a more lasting solution. If inefficient energy
delivery or energy transformation mechanisms are the reason
behind degenerative cell death, relieving the metabolic load on
the vulnerable neuronal clusters, by intervening through current
clinically approved therapeutics (such as brain stimulation and
pharmacology) could prove to be effective treatments (Adhihetty
and Beal, 2008; Spieles-Engemann et al., 2010; Seidl and
Potashkin, 2011; Musacchio et al., 2017).
In this paper, with the help of computational models, we
investigate the hypothesis that the cellular energy deficiency
in SNc could be the primary cause of SNc cell loss in
PD. The higher metabolic demand of SNc cells due to their
unique molecular characteristics, complex morphologies, and other
energy-demanding features perhaps make them more vulnerable
to energy deficit. Therefore, prolonged energy deprivation or
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insufficiency in such cells creates metabolic stress, eventually
leading to neurodegeneration. If we can aim to reduce the
metabolic stress on SNc cells, we can delay the progression of cell
loss in PD.
In the proposed modeling study, we focus on excitotoxicity in
SNc caused by STN which is precipitated by energy deficiency
(Greene and Greenamyre, 1996) and exploring simulated
therapeutic strategies for slowing down SNc cell loss. With the
help of computational models of neurovascular coupling, our
group had earlier explored the effect of rhythms of energy
delivery from the cerebrovascular system on neural function
(Gandrakota et al., 2010; Chander and Chakravarthy, 2012;
Chhabria and Chakravarthy, 2016; Philips et al., 2016). Recently,
we proposed a preliminary computational spiking network
model of STN-mediated excitotoxicity in SNc with a slightly
abstract treatment of apoptosis (Muddapu and Chakravarthy,
2017). Building on the previous version of the model, we
have improved the excitotoxicity model by incorporating more
biologically plausible dopamine plasticity and also explored the
therapeutic strategies to slow down or halt the SNc cell loss.
2. MATERIALS AND METHODS
All the nuclei were modeled as Izhikevich 2D neurons (Figure 1).
All the simulations were performed by numerical integration
using MATLAB (RRID:SCR_001622) with a time step (dt) of
0.1 s. The average time for 50-s simulation was around 10 h, and
it reduced to 5 h when ran on GPU card (Nvidia Quadro K620).
2.1. Izhikevich Neuron Model
Computational neuroscientists are often required to select
the level at which a given model of interest must cast, i.e.,
biophysical-level, conductance-based modeling level, spiking
neuron-level or rate-coded level. Biophysical models capture a
more biologically detailed dynamics but are computationally
expensive whereas rate-coded, point-neuron models are
computationally inexpensive but possess less biologically
detailed dynamics. To overcome this predicament, Izhikevich
FIGURE 1 | Proposed model architecture. The model architecture of
the proposed model of STN-mediated excitotoxicity in SNc. STN,
SubThalamic Nucleus; SNc, Substantia Nigra pars compacta; GPe, Globus
Pallidus externa.
(2003) developed spiking neuron models that are comparatively
computationally inexpensive yet capture various neuronal
dynamics. The proposed model of excitotoxicity consists of
SNc, STN, and Globus Pallidus externa (GPe) modeled using
Izhikevich neuron models arranged in a 2D lattice (Figure 1).
The population sizes of these nuclei in the model were selected
based on the neuronal numbers of these nuclei in rat basal
ganglia (Oorschot, 1996). The Izhikevich parameters for STN
and GPe were adapted from Michmizos and Nikita (2011)
and Mandali et al. (2015) and the parameters for SNc were
adapted from Cullen and Wong-Lin (2015). The firing rates
of these neuronal types were tuned to match the published
data (Modolo et al., 2007; Tripathy et al., 2014) by varying the
external bias current (Ixij). All parameters values are given in the
Table 1. The Izhikevich model consists of two variables, one
for membrane potential (vx) and the other one for membrane
recovery variable (ux).
dvxij
dt
= 0.04(vxij)
2 + 5vxij + 140− u
x
ij + I
x
ij + I
syn
ij (1)
duxij
dt
= a(bvxij − u
x
ij) (2)
if vxij ≥ vpeak
{
vxij ← c
uxij ← u
x
ij + d
}
(3)
where, vxij, u
x
ij, I
syn
ij , and I
x
ij are the membrane potential, the
membrane recovery variable, the total amount synaptic current
received and the external current applied to neuron x at location
(i, j), respectively, vpeak is the maximum membrane voltage set to
neuron (+30 mV) with x being GPe or SNc or STN neuron.
2.2. Synaptic Connections
The presence of excitatory synaptic connectivity from STN to
SNc was observed from anatomical and electrophysiology studies
(Kita and Kitai, 1987; Smith and Grace, 1992; Hamani et al.,
2004, 2017) and these connections might take part in controlling
the bursting activity of SNc (Smith and Grace 1992). The sizes
(number of neurons) of SNc (8× 8), STN (32× 32) and GPe (32
× 32) nuclei in the model were selected such that they match the
proportions as observed in the rat basal ganglia (Oorschot, 1996).
We also modeled convergent projections from STN to SNc as per
anatomical observations (Oorschot, 1996). Similarly, the synaptic
connectivity betweenGPe and STNwas considered one-to-one as
in Dovzhenok and Rubchinsky (2012) and Mandali et al. (2015).
The equations used to model synaptic connectivity are
τRecep ∗
dh
x→y
ij
dt
= −h
x→y
ij + S
x
ij(t) (4)
I
x→y
ij (t) =Wx→y ∗ h
x→y
ij (t) ∗ (ERecep − V
y
ij(t)) (5)
The NMDA currents are regulated by voltage-dependent
magnesium channel (Jahr and Stevens, 1990) which was
modeled as,
Bij(vij) =
1
1+ (Mg
2+
3.57 ∗ e
−0.062∗V
y
ij(t))
(6)
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TABLE 1 | Parameter values used in the proposed model.
Parameter(s) STN SNc GPe
Izhikevich parameters (a, b, c, d) a = 0.005,
b = 0.265,
c = −65,
d = 1.5
a = 0.0025,
b = 0.2,
c = −55,
d = 2
a = 0.1,
b = 0.2,
c = −65,
d = 2
External current (Ix ) ISTN= 3 ISNc= 9 IGPe= 4.25
Number of laterals (nlatx ) nlatSTN = 11 nlatSNc = 5 nlatGPe = 15
Radius of Gaussian laterals (Rx ) RSTN = 1.4 RSNc = 1.6 RGPe = 1.6
Synaptic strength within laterals (Ax ) ASTN = 1.3 ASNc = 0.1 AGPe = 0.1
Time decay constant for AMPA (τAMPA) 6 ms 6 ms 6 ms
Time decay constant for NMDA (τNMDA) 160 ms 160 ms 160 ms
Time decay constant for GABA (τGABA) 4 ms 4 ms 4 ms
Synaptic potential of AMPA receptor (EAMPA) 0 mV 0 mV 0 mV
Synaptic potential of NMDA receptor (ENMDA) 0 mV 0 mV 0 mV
Synaptic potential of GABA receptor (EGABA) −60 mV −60 mV −60 mV
Effect on the post-synaptic current (cd2) 0.1 0.1 0.1
Concentration of Magnesium (Mg2+) 1 nM 1 nM 1 nM
ms, milliseconds; mV, millivolts; nM, nanomolar.
where, Sxij is the spiking activity of neuron x at time t, τRecep
is the decay constant for synaptic receptor, h
x→y
ij is the gating
variable for the synaptic current from x to y, Wx→y is the
synaptic weight from neuron x to y, Mg2+ is the magnesium
ion concentration, V
y
ij is the membrane potential of the neuron
y for the neuron at the location (i, j) and ERecep is the receptor
associated synaptic potential (Recep = NMDA/AMPA/GABA).
The time constants of NMDA, AMPA, and GABA in GPe,
SNc, and STN were chosen from Götz et al. (1997) are given
in the Table 1.
2.3. Lateral Connections
Lateral connections are similar to collaterals of a neuron, and
here it is defined as connections within each neuronal population.
Earlier studies show the presence of lateral connections in
STN (Kita et al., 1983) and GPe (Kita and Kita, 1994). In the
case of SNc, the GABAergic interneurons were observed and
their control of SNc activity revealed by immunohistochemistry
studies (Hebb and Robertson, 1999; Tepper and Lee, 2007).
To simplify the model, the GABAergic interneurons were
replaced by GABAergic lateral connections in SNc population.
Experimental studies show that synaptic current from lateral
connections follows Gaussian distribution (Lukasiewicz and
Werblin, 1990) that is, nearby neurons will have more influence
than distant neurons. The lateral connections in various modules
in the current network (STN, GPe, and SNc) were modeled
as Gaussian neighborhoods (Mandali et al., 2015) and the
parameters used are given in the Table 1. Each neuron receives
synaptic input from a set number of neighboring neurons located
in a 2D grid of size nxn.
wm→mij,pq = Am ∗ e
−d2ij,pq
R2m (7)
d2ij,pq = (i− p)
2 + (j− q)2 (8)
where, wm→mij,pq is the lateral connection weight of neuron type m
at location (i, j), d2ij,pq is the distance from center neuron (p, q), Rm
is the variance of Gaussian, Am is the strength of lateral synapse,
m = GPe or SNc or STN.
2.4. Effect of DA on Synaptic Plasticity
Several experimental studies demonstrate dopamine-dependent
synaptic plasticity in STN (Hassani et al., 1997; Magill et al., 2001;
Yang et al., 2016) and GPe (Magill et al., 2001; Mamad et al.,
2015). Experimental observations show an increase in synchrony
in STN (Bergman et al., 1994, 1998) and GPe populations
(Bergman et al., 1998) at low DA levels. The effect of low
DA was implemented in the model by increasing in lateral
connections strength in STN population as in Hansel et al. (1995)
and similarly decrease in lateral connections strength in GPe
as in Wang and Rinzel (1993). Similarly, SNc populations also
showed an increase in synchrony at low DA levels (Hebb and
Robertson, 1999; Vandecasteele et al., 2005; Tepper and Lee,
2007; Ford, 2014) which was modeled similarly to the model of
DA-modulated GPe.
We modeled DA effect on the network as follows: as
DA level increases, the strength of the lateral connections in
STN decreases whereas, in GPe and SNc, lateral connection
weights become stronger. As the lateral connection weights
directly controls the amount of synaptic current each neuron
receives. All the neurons in STN population will tend to
fire together as the lateral connection weights increases (due
to excitatory synapses). However, in the case of SNc and
GPe it is contrary, that is, all the neurons will not tend
to fire together as the lateral connection weights increases
(due to inhibitory synapses). Lateral strength was modulated
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by DA as follows,
ASTN = s
max
STN ∗ e
(−cdstn∗DAs(t)) (9)
AGPe = s
max
GPe ∗ e
(cdgpe∗DAs(t)) (10)
ASNc = s
max
SNc ∗ e
(cdsnc∗DAs(t)) (11)
where, smaxSTN , s
max
GPe , and s
max
SNc are strength of the lateral connections
at the basal spontaneous activity of the population without any
external influence in STN, GPe, and SNc, respectively. cdstn, cdgpe,
and cdsnc were the factors by which dopamine affects the lateral
connections in STN, GPe, and SNc populations, respectively,
DAs(t) is the instantaneous dopamine level which is the spatial
average activity of all the neurons in SNc.
According to experimental studies, DA causes post-synaptic
effects on afferent currents in GPe and STN (Shen and Johnson,
2000; Smith and Kieval, 2000; Magill et al., 2001; Cragg et al.,
2004; Fan et al., 2012). DA causes post-synaptic effects on
afferent currents in SNc through somatodendritic DA receptors
(Jang et al., 2011; Courtney et al., 2012; Ford, 2014). Thus,
we included a factor (cd2), which regulates the effect of DA
on synaptic currents of GPe, SNc, and STN. As observed in
Kreiss et al. (1997), as DA level increases, the regulated current
decreases as follows:
Wx→y = (1− cd2 ∗ DAs(t)) ∗ wx→y (12)
where, Wx→y is the synaptic weight (STN → GPe, GPe→ STN,
STN → STN, GPe→ GPe, STN → SNc, SNc→ SNc), (cd2) is
the parameter that affects the post-synaptic current, DAs(t) is the
instantaneous dopamine level which is the spatial average activity
of all the neurons in SNc.
2.5. Total Synaptic Current Received by
Each Neuron
STN:
The total synaptic current received by a STN neuron at lattice
position (i, j) is the summation of lateral glutamatergic input
from other STN neurons considering both NMDA and AMPA
currents and the GABAergic input from the GPe neurons.
I
STNsyn
ij = I
NMDAlat
ij + I
AMPAlat
ij + I
GABA→STN
ij (13)
where, INMDAlatij and I
AMPAlat
ij are the lateral glutamatergic current
from other STN neurons considering both NMDA and AMPA
receptors, respectively, IGABA→STNij is the GABAergic current
from GPe neuron.
GPe:
The total synaptic current received by a GPe neuron at lattice
position (i, j) is the summation of the lateral GABAergic current
from other GPe neurons and the glutamatergic input from the
STN neurons considering both NMDA and AMPA currents.
I
GPesyn
ij = I
GABAlat
ij + I
NMDA→GPe
ij + I
AMPA→GPe
ij (14)
where, IGABAlatij is the lateral GABAergic current from other
GPe neurons, INMDA→GPeij and I
AMPA→GPe
ij are the glutamatergic
current from STN neuron considering both NMDA and AMPA
receptors, respectively.
SNc:
The total synaptic current received by a SNc neuron at
lattice position (i, j) is the summation of the lateral GABAergic
current from other SNc neurons and the glutamatergic
input from the STN neurons considering both NMDA and
AMPA currents.
I
SNcsyn
ij = I
GABAlat
ij + I
NMDA→SNc
ij + I
AMPA→SNc
ij (15)
where, IGABAlatij is the lateral GABAergic current from other
SNc neurons, INMDA→SNcij and I
AMPA→SNc
ij are the glutamatergic
current from STN neuron considering both NMDA and AMPA
receptors, respectively.
2.6. Neurodegeneration
According to Rodriguez et al. (1998), dopamine deficiency
in SNc leads to disinhibition and overactivity of the STN,
which in turn causes excitotoxic damage to its target structures,
including SNc itself. In order to simulate the SNc excitotoxicity
induced by STN, we incorporate a mechanism of programmed
cell death, whereby an SNc cell under high stress kills itself.
The stress on a given SNc cell was calculated based on
the firing history of the cell - higher firing activity causes
higher stress.
The stress of each SNc neuron at lattice position (i, j) at time t
due to excess firing is calculated as,
τstress ∗
dQxij
dt
= −Qxij + r
x
ij(t) (16)
where, rxij(t) is instantaneous mean firing rate of a SNc neuron
at lattice position (i, j) at time t, calculated with a fixed sliding
window1t (1 s) (Dayan and Abbott, 2005) as,
rxij(t) =
1
1t
∫ t
t−1t
dτρ(τ ) (17)
and,
ρ(τ ) =
n∑
i=1
δ(t − ti) (18)
Sequence of spike timing: ti = 1, 2, 3...n
If stress variable (Qxij) of a SNc neuron at lattice position (i, j)
crosses certain threshold (Sthres) then that particular SNc neuron
will be eliminated (Iglesias and Villa, 2008).
if Qxij(t) > Sthres, then v
x
ij(t) = 0 (19)
2.6.1. Estimating Rate of Degeneration
For a given course of SNc cell loss, the half-life is the
time taken for half of the SNc cells to be lost (t1/2). The
following equation was used to estimate the number of
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SNc cells (Nsc(t)) for a given course that survived after a
given time t.
Nsc(t) = N
0
sc ∗ e
−λt (20)
where, λ is the rate of degeneration (sec−1), N0sc is the number of
surviving SNc cells at t = 0.
To estimate the rate of degeneration λ from a given course of
SNc cell loss, the following equation was used,
λ =
ln 2
t1/2
(21)
The instantaneous rate of degeneration λ(t) was calculated by the
following equation,
λ(t) =
ln(Nsc(t))− ln(Nsc(t − 1))
t − (t − 1)
(22)
2.7. Neuroprotective Strategies
Pharmacological or surgical therapies that abolish the
pathological oscillations in STN or block the receptors on SNc
can be neuroprotective and might slow down the progression of
SNc cell loss (Rodriguez et al., 1998).
2.7.1. Glutamate Inhibition Therapy
Glutamate drug therapy can have neuroprotective effect on SNc
in two ways (1) Inactivation of NMDA (N-methyl-D-aspartate),
AMPA (2-amino-3-(5-methyl-3-oxo-1,2-oxazole-4-yl)
propanoic acid) or excitatory metabotropic glutamate (Group-I
- mGluR1/5) receptors (mGluR) by glutamate antagonists,
and (2) Activation of metabotropic glutamate (Group-II/III
- mGluR2,3/4,6,7,8) receptors by glutamate agonists. NMDA
antagonist MK-801 showed reduction of SNc cell loss in the
neurotoxic rats (Turski et al., 1991; Zuddas et al., 1992b; Brouillet
and Beal, 1993; Blandini, 2001; Armentero et al., 2006) and
primates (Zuddas et al., 1992a,b). AMPA antagonists such as
NBQX (Merino et al., 1999), LY-503430 (Murray et al., 2003) and
LY-404187 (O’Neill et al., 2004) exhibited neuroprotection of
SNc cells in the neurotoxic animal models. mGluR-5 antagonist
MPEP and MTEP showed neuroprotection in 6-OHDA lesioned
rats (Armentero et al., 2006; Hsieh et al., 2012; Ferrigno et al.,
2015; Fuzzati-Armentero et al., 2015) and MPTP-treated
primates (Masilamoni et al., 2011), respectively. Broad-spectrum
group II (Murray et al., 2002; Battaglia et al., 2003; Vernon et al.,
2005) and group III (Vernon et al., 2005; Austin et al., 2010)
agonists showed neuroprotection in neurotoxic rats. Selective
mGluR2/3 agonist 2R,4R APDC (Chan et al., 2010) and mGluR4
agonist VU0155041 (Betts et al., 2012) significantly attenuated
SNc cell loss in 6-OHDA lesioned rats.
The glutamate drug therapy was implemented in the proposed
excitotoxicity model by the following criterion,
WSTN→SNc(Nsc, t) =
{
W0STN→SNc, Nsc(t) > Ni
W0STN→SNc ∗ δGI , Nsc(t) ≤ Ni
(23)
where,WSTN→SNc(Nsc, t) is the instantaneous change in synaptic
weight of STN to SNc based on the number of surviving SNc
neurons at time t Nsc(t) is the instantaneous number of surviving
SNc neurons, W0STN→SNc is the basal connection strength of
STN to SNc, δGI is the proportion of glutamate inhibition, Ni
is the number representing SNc cell loss 〈i = 25% | 50% | 75%〉
at which therapeutic intervention was employed. In the present
study, we have considered 25% (cells lost = 16), 50% (cells lost =
32) and 75% (cells lost = 48) SNc cell loss as early, intermediate
and late stages of disease progression, respectively.
2.7.2. Dopamine Restoration Therapy
The neuroprotective effects of DA agonists therapy are thought
to be due to one or more of the following mechanisms:
(1) L-DOPA sparing, (2) Autoreceptor effects, (3) Antioxidant
effects, (4) Antiapoptotic effects, and (5) Amelioration of STN-
mediated excitotoxicity (Olanow et al., 1998; Grandas, 2000;
Schapira, 2003; Zhang and Tan, 2016). In the present study, we
focus on the amelioration of STN-mediated excitotoxicity. DA
agonists can restore the dopaminergic tone in the dopamine-
denervated brain, which results in increased inhibition in STN,
thereby diminishing STN-induced excitotoxicity on SNc neurons
(Olanow et al., 1998; Schapira and Olanow, 2003; Piccini and
Pavese, 2006; Vaarmann et al., 2013).
The dopamine agonist therapy was implemented in the
proposed excitotoxicity model by the following criterion,
DA(Nsc, t) =
{
DAs(t), Nsc(t) > Ni
DAs(t)+ δDAA, Nsc(t) ≤ Ni
(24)
where, DA(Nsc, t) is the instantaneous change in dopamine level
based on the number of surviving SNc neurons at time t Nsc(t)
is the instantaneous number of surviving SNc neurons, DAs(t)
is the instantaneous dopamine signal from the SNc neurons,
δDAA is the proportion of dopamine content restoration, Ni
is the number representing SNc cell loss at which therapeutic
intervention was employed.
2.7.3. Subthalamotomy
Subthalamotomy is still quite a common treatment amongst
patients in advanced stages of PD where patients stop responding
to L-DOPA (wearing-off) or chronic L-DOPA therapy results
in motor complications such as L-DOPA Induced Dyskinesias
(LID) (Alvarez et al., 2009; Obeso et al., 2017). It was reported
that STN lesioning exhibits neuroprotective effect which acts as
an antiglutamatergic effect in neurotoxic animal models (Piallat
et al., 1996; Chen et al., 2000; Carvalho and Nikkhah, 2001; Paul
et al., 2004; Wallace et al., 2007; Jourdain et al., 2014).
STN ablation was implemented in the proposed excitotoxicity
model by the following criterion,
if Nsc(t) ≤ Ni, then v
STN
ij (Ples, t) = 0 (25)
where, Ples is the lesion percentage of STN which is selected
from the following range: [5, 10, 20, 40, 60, 80, 100], Nsc(t) is
the instantaneous number of surviving SNc neurons, Ni is
the number representing SNc cell loss at which therapeutic
intervention was employed.
Frontiers in Neural Circuits | www.frontiersin.org 6 February 2019 | Volume 13 | Article 11
Muddapu et al. Excitotoxic Loss of Dopaminergic Cells in PD
2.7.4. Deep Brain Stimulation (DBS) in STN
DBS therapy is preferred over ablation therapy of STN due to the
potentially irreversible damage to the stimulated brain region in
ablation therapy. It has been reported that long-term stimulation
(DBS) of STN results in the slowdown of the progression of SNc
cell loss in animal models (Benazzouz et al., 2000; Maesawa et al.,
2004; Temel et al., 2006; Wallace et al., 2007; Spieles-Engemann
et al., 2010; Musacchio et al., 2017).
The DBS electrical stimulation was given in the form of
current or voltage pulses to the target neuronal tissue (Cogan,
2008). The effect of DBS therapy was modeled as external
stimulation current given to the entire or part of the STN
module in the form of Gaussian distribution (Rubin and Terman,
2004; Hauptmann and Tass, 2007; Foutz and McIntyre, 2010;
Mandali and Chakravarthy, 2016). The DBS parameters such
as amplitude (ADBS), frequency (fDBS =
1
TDBS
) and pulse width
(δDBS) were adjusted by using clinical settings as a constraint
(Moro et al., 2002; Garcia et al., 2005), in order to reduce the
synchrony in STN population along with the minimal rise in the
firing rate. In addition to exploring DBS parameters, a range of
stimulus waveforms (such as rectangular monophasic (MP) and
biphasic (BP) current pulses) and different types of stimulation
configurations (such as single contact point (SCP), four contact
points (FCP) and multiple contact points (MCP)) were also
implemented (Figure 2) (Cogan, 2008; Lee et al., 2016).
In the present study, the current pulses which given to
neuronal network are in the form of monophasic and biphasic
waveforms. The monophasic current pulse (PMP) was generated
as the following,
PMP(t) =
{
ADBS, tk ≤ t < tk + δDBS
0, else
(26)
where, tk are the onset times of the current pulses, ADBS is the
amplitude of the current pulse, δDBS is the current pulse width.
The biphasic current pulse (PBP) was generated as
the following,
PMP(t) =


ADBS, tk ≤ t < tk +
δDBS
2
−ADBS, tk +
δDBS
2 ≤ t < tk + δDBS
0, else
(27)
where, tk are the onset times of the current pulses, ADBS is the
amplitude of the current pulse, δDBS is the current pulse width.
The influence of stimulation on a particular neuron will
depend on the position of the stimulation electrode in the
neuronal network (Cogan, 2008). The effect of stimulation
will decay as the distance between electrode position (ic, jc)
and neuronal position (i, j) increased which was modeled as a
Gaussian neighborhood (Mandali and Chakravarthy, 2016). We
have assumed that the center of the electrode to be the mean
of the Gaussian which coincides with the lattice position (ic, jc)
and the spread of stimulus current was controlled by the width
of the Gaussian (σ ).
IDBS−STNij (t) =
Nxcp∑
β=1
M β (t) ∗ Py(t) ∗ e
−
[
(i−ic)2+(j−jc)2
]
σ2
DBS−STN (28)
where, IDBS−STNij (t) is the DBS current received by STN neuron at
position (i, j) considering lattice position (ic, jc) as the electrode
contact point at time t, M β (t) is the indicator function which
controls the activation of stimulation site β , Nxcp is the number
of activated stimulation contact points for different stimulation
configurations x = [SCP, FCP,MCP] (NSCPcp = 1,N
FCP
cp = 4,N
MCP
cp =
Number of neurons in simulated network - 1024 ), Py(t) is the
current pulse at time t for y = [MP,BP], σDBS−STN is used to
control the spread of stimulus current in STN network.
DBS was implemented in the proposed excitotoxicity model
by the following criterion,
IDBS−STNij (Nsc, t) =
{
0, Nsc(t) > Ni
IDBS−STNij (t), Nsc(t) ≤ Ni
(29)
where, IDBS−STNij (t) is the instantaneous change in the stimulation
current to STN neuron at position (i, j) based on the number
of surviving SNc neurons at time t, Nsc(t) is the instantaneous
number of surviving SNc neurons,Ni is the number representing
SNc cell loss at which therapeutic intervention was employed.
2.7.5. Antidromic Activation
The mechanism of how DBS alleviates advanced PD symptoms
is not precise. One of the theories behind the therapeutic effect
of DBS is activation of afferent connections of STN which
results in antidromic activation of cortical, GPi or GPe neurons
(Lee et al., 2004; McIntyre et al., 2004; Hammond et al., 2008;
Montgomery and Gale, 2008; Kang and Lowery, 2014; Chiken
and Nambu, 2015). In our study, we implemented the antidromic
activation of GPe during DBS therapy. Antidromic activation
was implemented similarly to Mandali and Chakravarthy (2016),
where a percentage of DBS current given to STN neurons were
given directly to GPe neurons. Similar to DBS applied to STN,
external stimulation current was given to GPe neuron in the
form of Gaussian distribution. The specifications of antidromic
activation were described by the following equation,
IDBS−GPeij (t) =
Nxcp∑
β=1
M β (t) ∗ Py(t) ∗ e
−
[
(i−ic)2+(j−jc)2
]
σ2DBS−GPe (30)
where, IDBS−GPeij (t) is the DBS current received by GPe neuron at
position (i, j) considering lattice position (ic, jc) as the electrode
contact point, M β (t) is the indicator function which controls
the activation of stimulation site β , Nxcp is the number of
activated stimulation contact points for different stimulation
configurations x = [SCP, FCP,MCP] (NSCPcp = 1,N
FCP
cp = 4,N
MCP
cp =
Number of neurons in simulated network - 1024), Py(t) is the
current pulse at time t for y = [MP,BP], ADBS−GPe is the portion
of DBS current pulse amplitude given as antidromic activation to
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FIGURE 2 | Different DBS protocol used in the study. (1) DBS stimulation waveforms. (2) DBS stimulation configurations. DBS, Deep Brain Stimulation; ADBS,
Amplitude of DBS current pulse; δDBS, Pulse width of DBS current pulse; TDBS(1/fDBS), frequency of DBS current pulse; SCP, Single Contact Point; FCP, Four
Contact Point; MCP, Multiple Contact Point.
GPe neurons, σDBS−GPe is used to control the spread of stimulus
current in GPe ensemble.
TheDBS therapy with antidromic activationwas implemented
in the proposed excitotoxicity model by the following criterion,
IDBS−STNij (Nsc, t) =
{
0, Nsc(t) > Ni
IDBS−STN−AAij (t), Nsc(t) ≤ Ni
(31)
IDBS−GPeij (Nsc, t) =
{
0, Nsc(t) > Ni
IDBS−GPeij (t), Nsc(t) ≤ Ni
(32)
where, IDBS−STN−AAij (t) is the DBS current received
by STN neuron at position (i, j) considering lattice
position (ic, jc) as the electrode contact point with
antidromic activation (ADBS−GPe = PerAA ∗ ADBS−STN ;
A
′
DBS−STN = (1− PerAA) ∗ ADBS−STN), PerAA is the proportion
of ADBS−STN applied as ADBS−GPe, A
′
DBS−STN is the portion of
DBS current pulse amplitude given to STN neurons during
antidromic activation, Nsc(t) is the instantaneous number of
surviving SNc neurons, Ni is the number representing SNc cell
loss at which therapeutic intervention was employed.
2.7.6. STN Axonal & Synaptic Failures
In-vitro recordings observed depression in the synapse of STN
neurons with SNc and is believed to be due to the delivery of
continuous high-frequency stimulation pulses (Ledonne et al.,
2012). This synaptic depression caused by increased STN activity
during DBS arises due to an amalgamation of axonal and synaptic
failures in the STN (Shen and Johnson, 2008; Ammari et al., 2011;
Moran et al., 2011, 2012; Zheng et al., 2011; Carron et al., 2013;
Rosenbaum et al., 2014).
The effect of synaptic depression due to DBS of the STN was
implemented by the following criterion,
WSTN→SNc(SDBS, t) =
{
WSTN→SNc, SDBS = OFF
WSTN→SNc ∗WASF(PerASF), SDBS = ON
(33)
where, WSTN→SNc(SDBS, t) is the instantaneous change in
synaptic weight of STN to SNc based SDBS = {ON, OFF}, SDBS
is DBS stimulation, WASF is the weight matrix based on the
percentage of axonal and synaptic failures (PerASF).
WSTN→GPe(SDBS, t) =
{
WSTN→GPe, SDBS = OFF
WSTN→GPe ∗WASF(PerASF), SDBS = ON
(34)
where, WSTN→GPe(SDBS, t) is the instantaneous change in
synaptic weight of STN to GPe based SDBS = {ON, OFF}, SDBS
is DBS stimulation, WASF is the weight matrix based on the
percentage of axonal and synaptic failures (PerASF).
2.8. Network Analysis
We analyzed the dynamics of the network (STN-GPe-SNc) by
firing frequency (Dayan and Abbott, 2005), network synchrony
(Pinsky and Rinzel, 1995) and bursting measures (van Elburg and
vanOoyen, 2004). The equations used to compute thesemeasures
are described below.
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2.8.1. Frequency of Firing
The spike-count firing rate is themeasure of the number of action
potentials for a given duration of time (Dayan and Abbott, 2005).
The instantaneous mean firing rate (rxij(t)) of a neuron at lattice
position (i, j) at time t was calculated with a fixed sliding window
1t (0.1 s) which is similarly to Equations (17), (18). The mean
firing rate of the population of neurons is simply the average of
instantaneous mean firing rate across the number of neurons and
the simulation time.
2.8.2. Synchronization
Neuronal synchronization is the measure of synchronicity (high
synchrony - almost all neurons firing at once, low synchrony
- least number of neurons firing at once) in the population of
neurons within a network (Golomb, 2007). We had quantified
the synchrony in the population of neurons at time t by following
equation (Pinsky and Rinzel, 1995),
Rx(t) =
1
N ∗ ei∗θ(t)
N∑
j=1
ei∗φj(t) (35)
φj(t) = 2 ∗ π ∗
(Tj,k − tj,k)
tj,k+1 − tj,k
(36)
where, Rx(t) is the instantaenous synchronization measure
(0 ≤ Rx(t) ≤ 1), x being GPe or SNc or STN neuron, N is the
number of neurons in the network, θ(t) is the instantaneous
average phase of neurons, φj(t) is the instantaneous phase of jth
neuron, tj,k and tj,k+1 are the spike times of kth and (k+ 1)th
spike of jth neuron, respectively, Tj,k ∈ [tj,k, tj,k+1].
2.8.3. Bursting
If a neuron fires repeatedly with discrete groups of spikes, this
dynamic state is termed as burst. Between two bursts, there is a
period of quiescence where there will be no spikes. Burst can have
two (doublet), three (triplet), four (quadruplet) or many spikes in
it (Izhikevich, 2006). We had quantified the bursting of a neuron
at lattice position (i, j) across time by following equation (van
Elburg and van Ooyen, 2004),
Bi,j =
2 ∗ Var(ti,j,k+1 − ti,j,k)− Var(ti,j,k+2 − ti,j,k)
2 ∗ E2(ti,j,k+1 − ti,j,k)
(37)
where, Bi,j is the measure of bursting of a neuron at lattice
position (i, j), Var is the variance of the spike times, E is the
expected value (mean) of the spike times, ti,j,k, ti,j,k+1 and ti,j,k+2
are the spike times of kth, (k+ 1)th and (k+ 2)th spike of a
neuron at lattice position (i, j), respectively.
3. RESULTS
We have investigated the Izhikevich parameters of STN, SNc
and GPe which were chosen from the literature (Michmizos
and Nikita, 2011; Cullen and Wong-Lin, 2015; Mandali et al.,
2015) for their characteristic firing pattern and other biological
properties (Figure 3-1). We then extensively studied the effect
of lateral connections in the network of neurons (Figure 3-2).
Next, we have explored the effect of dopamine on the network
of GPe, SNc, and STN neurons and compared with published
data (Figure 4).
Then, we showed the results of the proposed excitotoxicity
model which exhibits STN-mediated excitotoxicity in SNc
(Figures 5, 6) and studied their sensitivity to parameter
uncertainty (Figure 7). Finally, we have explored current
therapeutics such as glutamate inhibition (Figure 8), dopamine
restoration (Figure 9), subthalamotomy (Figure 10) and
deep brain stimulation (Figures 11, 12) which might
have a neuroprotective effect on the progression of SNc
cell loss.
3.1. Characteristic Firing of Different
Neuronal Types
The firing response of a single neuron to different external
current input was characterized for the three different neuronal
types involved in the excitotoxicity model (Figure 3-1). In the
proposed model, we adjusted Ixij and other parameters of the
Izhikevich model such that the basal firing frequencies of the
different neuronal types match with experimental data (Modolo
et al., 2007; Tripathy et al., 2014). The adjusted values can be seen
in the Table 1.
The SNc neurons experimentally exhibit two distinct firing
patterns: low-frequency irregular tonic or background firing (3–
8 Hz) and high-frequency regular phasic or burst firing (∼20
Hz) (Grace and Bunney, 1984a,b). The Izhikevich parameters
which were chosen for SNc neurons configured the model to
exhibit both types of firing patterns. Other properties such as
doublet-spikes which were occasionally observed experimentally
(Grace and Bunney, 1983) were also exhibited (Figure 3-1A). In
the present model, SNc neuron basal firing rate were required
to be ∼4 Hz which is in the range of 3–8 Hz observed
experimentally (Grace and Bunney, 1984a). Similar to SNc, STN
neurons also exhibit tonic pacemaking firing and phasic high-
frequency bursting (Beurrier et al., 1999; Allers et al., 2003).
The basal firing rate of STN neurons was required to be ∼13
Hz which is in the range of 6–30 Hz observed experimentally
(Allers et al., 2003; Lindahl et al., 2013). The STN neurons also
exhibit characteristic inhibitory rebound which was observed
experimentally (Figure 3-1B) (Hamani et al., 2004; Johnson,
2008). Unlike SNc and STN, GPe neurons exhibit high-frequency
tonic firing which was interpreted by bursts and pauses (Kita
and Kita, 2011; Hegeman et al., 2016). The Izhikevich parameters
which were chosen for GPe neurons were able to exhibit
high-frequency firing without any bursts (Figure 3-1C). The
basal firing rate of GPe neurons was required to be ∼30 Hz
which is in the range of 17–52 Hz observed experimentally
(Lindahl et al., 2013).
3.2. Behavior Regimes With Varying
Collateral Strength and Radius
We now study the network dynamics of each of the three
neuronal types in a 2D array with lateral connections. The
effect of network structural properties such as the strength and
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FIGURE 3 | Characteristic behavior in the single-neuron and the population of neurons of different neuronal types. (1) Characteristics firing patterns of SNc (A), STN
(B), and GPe (C) for varying external currents (orange line - current in picoAmpere (pA)). (2) The response of STN (A), GPe (B), and SNc (C) populations for varying
lateral connection strength (Ax ) and radius (Rx ) at the level of network properties [Frequency (i), Synchrony (ii), Burst Index (iii)]. Iext, External current applied; STN,
SubThalamic Nucleus; SNc, Substantia Nigra pars compacta; GPe, Globus Pallidus externa.
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FIGURE 4 | Dopamine effect on the basal activity of different neuronal types. (1) The response of STN (A), GPe (B), and SNc (C) populations for varying dopamine
levels at the level of network properties [Frequency (i), Synchrony (ii), and Burst Index (iii)]. (2) The response of STN-GPe network without (A) & with (B) dopamine -
Raster plots of STN (i) & GPe (ii) populations overlaid with spike-count firing rate (orange line), Synchrony plots of STN (iii), GPe (iv), and combined STN-GPe (v).
STN, SubThalamic Nucleus; SNc, Substantia Nigra pars compacta; GPe, Globus Pallidus externa.
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FIGURE 5 | Simulation plots of whole and step-wise mechanism (I) of the proposed excitotoxicity model. (1) Whole 50 sec simulation plots of the proposed
excitotoxicity model. (2) Part-I of (1) Simulation plots of STN-SNc loop dynamics - Mean firing rate (1 s) of STN (A) & SNc (C), Synchrony (syn) of STN (B) & SNc (D),
Progression of SNc cell loss (E). STN, SubThalamic Nucleus; SNc, Substantia Nigra pars ompacta; GPe, Globus Pallidus externa.
neighborhood size of the lateral connections on the network
functional properties such as average firing rate, network
synchrony, and burst index was studied (Figure 3-2). The
suitable values of lateral connection strength and radius for each
neuronal type were chosen in correlation with experimental data
(Humphries et al., 2006; Tepper and Lee, 2007). The selected
values can be seen in the Table 1. As specified above, Ixij, Ax and
Rx was adjusted such that the basal population activity correlated
well with the experimental data (Humphries et al., 2006;
Tepper and Lee, 2007).
The network dynamics of STN plays a vital role in the
proposed model of excitotoxicity, in this scenario we have
studied the role of lateral connections in regulating STN network
properties. The basal STN population activity without lateral
connections showed regular spiking without any bursting type
of behavior. Contrarily, the basal STN population activity with
lateral connections showed the bursting type of activity (not
shown here).
3.3. Dopamine Effect on the Basal Activity
of Different Neuronal Populations
From the simulated results, it is clear that as DA level increases
the mean firing rate decreases in STN, increases in GPe and
decreases in SNc (Figure 4-1). The network synchrony decreases
in all neuronal populations as DA levels increases. However, in
the case of STN, the decrease is not monotonic (Figure 4-1Aii)
where high synchrony was observed at moderate levels of DA,
with synchrony falling on either side. This high synchronicity
at moderate levels of DA is a result of the change in firing
pattern from asynchronous bursting to synchronous spiking
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FIGURE 6 | Simulation plots of step-wise mechanisms (II, III) of the proposed excitotoxicity model. (1) Part-II of (Figure 5-1) Stress-induced neurodegeneration in
SNc. (2) Part-III of (Figure 5-1) STN-mediated runaway effect of neurodegeneration in SNc - Mean firing rate (1 s) of STN (A) & SNc (C), Synchrony (syn) of STN (B) &
SNc (D), Progression of SNc cell loss (E). STN, SubThalamic Nucleus; SNc, Substantia Nigra pars compacta; GPe, Globus Pallidus externa.
which can be correlated with burst index (Figure 4-1Aiii) in STN
population. In the dopamine-depleted condition, STN shows
the bursting type of firing pattern which was exhibited by
our model consistent with published studies (Vila et al., 2000;
Ammari et al., 2011; Park et al., 2015). The following trend of
STN activity was observed when DA level increases from 0 to
1: synchronous bursting, asynchronous bursting, synchronous
spiking and asynchronous spiking. At very low DA levels (0–0.1),
the STN exhibits regular bursting (Figure 4-1Aiii) with high
synchrony (Figure 4-1Aii). At low DA levels (0.1–0.3), the STN
exhibits an irregular mixed mode of bursting and singlet-spiking
with low synchrony (Figure 4-1Aii). At moderate DA levels (0.3–
0.7), the STN exhibits regular singlet-spiking (Figure 4-1Aiii)
with high synchrony (Figure 4-1Aii). Moreover, at high DA
levels (0.3–1), the STN exhibits irregular singlet-spiking with low
synchrony (Figure 4-1Aii).
STN-GPe dynamics is known to play an important role in
PD pathological oscillations that are thought to be strongly
related to the cardinal symptoms of PD (Bergman et al.,
1994; Brown, 2003; Litvak et al., 2011; Park et al., 2011).
Numerous computational models were developed to explain
the pathological oscillations in STN-GPe (Terman et al., 2002;
Pavlides et al., 2015; Shouno et al., 2017). The connectivity
pattern between STN and GPe was explored by using a
conductance-based model (Terman et al., 2002) which exhibited
different rhythmic behaviors. In our model, the connectivity
pattern between STN and GPe was considered to be dopamine-
dependent (Cragg et al., 2004; Mandali et al., 2015) and
spontaneous activity of the STN-GPe network was studied
with no external input current. Under normal DA conditions,
low synchrony and minimal oscillations were exhibited by the
STN-GPe network (Figure 4-2B) (Kang and Lowery, 2013).
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FIGURE 7 | Sensitivity of the proposed model toward parameter uncertainty. Time taken for 50% SNc cell loss for varying stress threshold (Qthres) (1) and connection
strength from STN→SNc (WSTN→SNc) (2). Rate of degeneration (λ) for varying stress threshold (Qthres) (3) and connection strength from STN→SNc (WSTN→SNc)
(4). STN, SubThalamic Nucleus; SNc, Substantia Nigra pars compacta.
It was reported that dopamine-depleted condition results in
pathological oscillations in STN characterized by high synchrony
and beta range oscillations (Brown et al., 2001; Weinberger
et al., 2006; Park et al., 2010, 2011; Lintas et al., 2012;
Kang and Lowery, 2013; Pavlides et al., 2015). In our model
during dopamine-depleted conditions, high synchrony and the
higher rate of oscillations were exhibited in the STN-GPe
network, and beta range oscillations were also observed in STN
population (Figure 4-2A).
3.4. STN-Induced Excitotoxicity in SNc
The proposed excitotoxicity model was able to exhibit STN-
mediated excitotoxicity in SNc which was precipitated by
energy deficiency (Albin and Greenamyre, 1992; Beal et al.,
1993; Greene and Greenamyre, 1996; Rodriguez et al., 1998;
Blandini, 2001, 2010; Ambrosi et al., 2014) (Figures 5,
6). For a more detailed explanation of the excitotoxicity
results obtained, we have sub-divided 50 s simulation
into three parts - (I) STN-SNc loop dynamics (normal
condition), (II) Stress-induced neurodegeneration in SNc
(pre-symptomatic PD condition), and (III) STN-mediated
runaway effect of neurodegeneration in SNc (symptomatic
PD condition).
3.4.1. (I) STN-SNc Loop Dynamics
In the first part of the simulation, connectivity between STN and
SNc were introduced at t = 0, and the model exhibited decreased
synchrony in STN and SNc over time (Figure 5-2B). The results
showed the pivotal role of dopamine in modulating STN activity
(Cragg et al., 2004; Lintas et al., 2012; Yang et al., 2016). The
excitatory drive from STN to SNc results in decreased synchrony
in SNc due to increased inhibitory drive from lateral connections
(Figure 5-2D). During this whole process, the stress threshold
(Qthres = 11.3) was fixed, and there was no SNc cell loss due to
stress (Figure 5-2E).
3.4.2. (II) Stress-Induced Neurodegeneration in SNc
In the second part of the simulation, stress threshold was
slightly reduced from Qthres = 11.3 to Qthres = 10.8 at t = 10s
to replicate PD-like condition in the model where stress-
induced neurodegeneration gets initiated. The model exhibited
stress-induced neurodegeneration in SNc where SNc cells
start dying when stress variable (Qxij) exceeds the stress
threshold (Qthres) which acts like an apoptotic threshold
(Figure 6-1E). It was observed that there was no increased
synchrony in the STN population as a result of SNc cell
loss (Figure 6-1B). However, there was increased synchrony
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FIGURE 8 | Simulation plots for Glutamate Inhibition (GI) therapy. Progression of SNc cell loss for 90, 50, and 10% GI at early (25%) (1), intermediate (50%) (3) and
late (75%) (5) stages of SNc cell loss. Instantaneous rate of degeneration (λ) for 90, 50, and 10% GI at early (25%) (2), intermediate (50%) (4) and late (75%) (6) stages
of SNc cell loss. SNc, Substantia Nigra pars compacta.
in the SNc population (Figure 6-1D) which might be due to
reduced inhibitory drive from lateral connections as a result of
SNc cell loss.
3.4.3. (III) STN-Mediated Runaway Effect of
Neurodegeneration in SNc
In the third part of the simulation, no parameters were
changed, but after t = 40s, there was a rise in STN synchrony
as a result of stress-induced SNc cell loss (Figure 6-2).
A substantial amount of SNc cell loss (more than 50%)
resulted in increased synchrony (Figure 6-2B) and firing
rates (Figure 6-2A) of the STN population. As the STN
synchrony increased, runaway effect kicks in where increased
STN excitatory drive to SNc cells result in hastening
the stress-induced neurodegeneration of remaining SNc
cells (Figure 6-2E).
3.5. Sensitivity of Excitotoxicity Model
Toward Parameter Uncertainty
To check the sensitivity of excitotoxicity model for different
parametric values, we have considered two factors which
can maximally influence the output results. Firstly, stress
threshold (Qthres) which is analogous to the apoptotic
threshold and is assumed to be dependent on the amount
of available energy to the cell (Albin and Greenamyre,
1992; Greene and Greenamyre, 1996). Secondly, the
synaptic weight between STN and SNc (WSTN→SNc) which
is analogous to synaptic modification and is assumed to
be modulated by the excitatory drive from STN to SNc
(Hasselmo, 1994, 1997).
3.5.1. Stress Threshold (Qthres)
Simulation results showed that the time taken for 50% SNc cell
loss (t1/2) increases as the stress threshold increases (Figure 7-1).
The rate of degeneration or degeneration constant (λ) is the
ratio of the number of SNc cells that degenerate in a given
period of time compared with the total number of SNc cells
present at the beginning of that period. The rate of degeneration
(λ) decreases as the stress threshold increases (Figure 7-3).
These results show the importance of stress threshold in
regulating excitotoxic damage to SNc and also support the idea
of “weak excitotoxicity hypothesis” where SNc cells showed
increased susceptibility to glutamate due to impaired cellular
energy metabolism (Albin and Greenamyre, 1992; Greene and
Greenamyre, 1996).
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FIGURE 9 | Simulation plots for Dopamine Restoration (DR) therapy. Progression of SNc cell loss for 100, 50, and 10% DR at early (25%) (1), intermediate (50%) (3)
and late (75%) (5) stages of SNc cell loss. Instantaneous rate of degeneration (λ) for 100, 50, and 10% DR at early (25%) (2), intermediate (50%) (4) and late (75%) (6)
stages of SNc cell loss. SNc, Substantia Nigra pars compacta.
3.5.2. STN-SNc Synaptic Weight (WSTN→SNc)
Simulation results showed that time taken for 50% SNc cell
loss (t1/2) decreases as the STN-SNc synaptic weight increases
(Figure 7-2). The rate of degeneration (λ) increases as the STN-
SNc synaptic weight increases (Figure 7-4). These results show
the extent of STN influence in the causation of excitotoxicity
in SNc. They also support the notion that STN-mediated
excitotoxicity might play a major role in SNc cell loss in
PD condition (Rodriguez et al., 1998; Blandini, 2001, 2010;
Ambrosi et al., 2014).
3.6. Strategies for Neuroprotection of SNc
Wenow extend the proposed excitotoxicmodel to study the effect
of various therapeutic interventions on the progression of SNc
cell loss. The following three types of interventions which were
simulated: (1) drugs, (2) surgical interventions, and (3) Deep
Brain Stimulation (DBS).
3.6.1. Glutamate Inhibition Therapy
The effect of glutamate agonists and antagonists on the
progression of SNc cell loss was implemented in the manner
specified in the methods section. The onset of glutamate therapy
at different stages of SNc cell loss showed that cell loss was
delayed or halted (Figure 8). For the glutamate therapy which
is initiated at 25, 50, and 75% SNc cell loss, the progression
of SNc cell loss was halted when the percentage of glutamate
inhibition administrated was above 50%. As the glutamate dosage
increases the progression of SNc cell loss delays and after a
particular dosage of glutamate inhibitors the SNc cell loss halts.
There was no change in the course of SNc cell loss for low levels
of glutamate inhibition (Figures 8-1, 8-3, 8-5). The peak of the
instantaneous rate of degeneration decreases as the therapeutic
intervention is delayed in the case of 10% glutamate inhibition
(Figures 8-2, 8-4, 8-6).
3.6.2. Dopamine Restoration Therapy
The effect of dopamine agonists on the progression of SNc
cell loss was also implemented in the manner specified in the
methods section. The onset of dopamine agonist therapy at
different stages of SNc cell loss showed that the progression
of cell loss was only delayed (Figure 9). For the dopamine
agonists therapy which is initiated at 25, 50, and 75% SNc
cell loss, the progression of SNc cell loss was delayed when
the percentage of dopamine restoration was a mere 10%. The
neuroprotective effect of dopamine agonist therapy is dependent
on the level of restoration of dopamine tone on the STN.
Frontiers in Neural Circuits | www.frontiersin.org 16 February 2019 | Volume 13 | Article 11
Muddapu et al. Excitotoxic Loss of Dopaminergic Cells in PD
FIGURE 10 | Simulation plots for SuthalamoTomy (ST) therapy. Progression of SNc cell loss for 80, 40, 10, and 5% ST at early (25%) (1), intermediate (50%) (3) and
late (75%) (5) stages of SNc cell loss. Instantaneous rate of degeneration (λ) for 80, 40, 10, and 5% GI at early (25%) (2), intermediate (50%) (4) and late (75%) (6)
stages of SNc cell loss. SNc, Substantia Nigra pars compacta.
In other words, as the dopamine content in STN increases,
the progression of SNc cell loss delays. Unlike glutamate
inhibition, the progression of SNc cell loss was not halted
even at 100% dopamine restored in all the case of intervention
(Figures 9-1, 9-3, 9-5). The dopamine restoration therapy did
not have much effect on the instantaneous rate of degeneration
(Figures 9-2, 9-4, 9-6).
3.6.3. Subthalamotomy
The effect of subthalamotomy on the progression of SNc cell
loss was implemented in a way described in the methods
section. The onset of STN ablation therapy at different stages
of SNc cell loss showed that progression of cell loss was
delayed or halted (Figure 10). The neuroprotective effect of
subthalamotomy is dependent on the proportion of lesioning
of STN population. In other words, as the proportion of STN
lesioning increases the progression of SNc cell loss delays and
halts only when almost all of the STN population is lesioned
(Figures 10-1, 10-3, 10-5). The progression of SNc cell loss is
halted only at 100% STN lesioning in all cases of intervention
(not shown here). However, as the proportion of STN lesioning
decreases, the rate of degeneration increases. Similarly to
dopamine restoration therapy, subthalamotomy also did not
have much effect on the instantaneous rate of degeneration
(Figures 10-2, 10-4, 10-6).
3.6.4. Deep Brain Stimulation of STN
The effect of deep brain stimulation on the progression of SNc
cell loss was implemented in the way described in the methods
section. Along with the stimulation of STN, the inhibitory drive
to STN through the afferent connections as result of antidromic
activation of the GPe population and the synaptic depression in
STN as result of increased axonal and synaptic failures in STN
were incorporated in the model.
As specified earlier, different stimulation configurations and
stimulus waveforms were implemented while exploring the
optimal DBS parameters for therapeutic benefits. The STN
population response for different types of DBS protocol was
simulated. To study the neuroprotective effect, stimulation
parameters which reduce the STN overactivity (Meissner et al.,
2005) during dopamine depletion condition were chosen
(Table 2). The biphasic stimulus pulse shows more therapeutic
benefits than monophasic stimulus pulse; biphasic current
alleviates the STN pathological activity without increasing the
firing rate of STN population as a whole. The four-contact
point type of stimulation configuration required lesser stimulus
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FIGURE 11 | Simulation plots for Monophasic DBS therapy. Profiling of monophasic stimulus waveform for different stimulation configuration in order to achieve the
maximal neuroprotective effect of DBS. Confusion matrices for SCP (1), FCP (2), and MCP (3) configurations showing survival ratios of SNc cells for different
percentage activation of antidromic activation and STN axonal & synaptic failures at early (25%) (A), intermediate (50%) (B) and late (75%) (C) stages of SNc cell loss.
Ratios around 0 is indicated as forthwith (indigo), ratios around 0.5 is indicated as delayed (light green), and ratios around 1 is indicated as halted (yellow). DBS, Deep
Brain Stimulation; SNc, Substantia Nigra pars compacta; STN, SubThalamic Nucleus; SCP, Single Contact Point; FCP, Four Contact Point; MCP, Multiple Contact
Point.
amplitude for producing the same effect when compared with
the other two configurations. From these studies, we can say that
four-contact point configuration with biphasic stimulus pulse
gives maximum therapeutic benefits from the neuroprotective
point of view.
To understand the neuroprotective therapeutic mechanism
of DBS in PD (Benazzouz et al., 2000; Maesawa et al.,
2004; Wallace et al., 2007; Spieles-Engemann et al., 2010;
Musacchio et al., 2017), we have investigated some of the
prominent hypotheses regarding the therapeutic effect of DBS
viz., (1) excitation hypothesis, (2) inhibition hypothesis and
most recent one (3) disruptive hypothesis (McIntyre et al., 2004;
Chiken and Nambu, 2015).
The excitation hypothesis was implemented by direct
stimulation of the STN population in the proposed excitotoxicity
model. The simulation results show that DBS to STN diminishes
the pathological synchronized activity but in turn increases
the firing rate of the STN population which was not apt for
neuroprotection. Next, we have implemented the inhibition
hypothesis where antidromic activation of GPe neurons during
STN-DBS is highlighted, thereby increasing the inhibitory
drive to STN (Mandali and Chakravarthy, 2016). In this
scenario also, the inhibitory drive from GPe was not sufficient
to produce comprehensive neuroprotection (Figures 11, 12).
On average FCP stimulus configuration produced better
neuroprotective effect compared to other two configurations
in both monophasic and biphasic current (Figures 11-2, 12-2).
Moreover, MCP stimulus configuration results in worsening the
disease progression by hastening the SNc cell loss in monophasic
stimulus (Figure 11-3), but in biphasic stimulus, neuroprotection
increased with higher levels of antidromic activation in all stages
of therapeutic intervention (Figure 12-3).
Finally, the disruptive hypothesis was implemented by
increasing the proportion of axonal and synaptic failures in
STN population (Rosenbaum et al., 2014). From simulation
results, it was observed that the progression of SNc cell loss
was delayed or halted as the percentage of STN axonal and
synaptic failures increased (Figures 11, 12). On average FCP
stimulus configuration produced better neuroprotective effect
compared to other two configurations in both monophasic and
biphasic currents (Figures 11-2, 12-2). For the higher percentage
of STN axonal and synaptic failures also, the neuroprotective
effect was not pronounced in monophasic MCP DBS setting
(Figure 11-3), but in biphasic MCP DBS setting neuroprotection
increased with the higher percentage of STN axonal and synaptic
failures (Figure 12-3).
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FIGURE 12 | Simulation plots for Biphasic DBS therapy. Profiling of biphasic stimulus waveform for different stimulation configuration in order to achieve the maximal
neuroprotective effect of DBS. Confusion matrices for SCP (1), FCP (2), and MCP (3) configurations showing survival ratios of SNc cells for different percentage
activation of antidromic activation and STN axonal & synaptic failures at early (25%) (A), intermediate (50%) (B) and late (75%) (C) stages of SNc cell loss. Ratios
around 0 is indicated as forthwith (indigo), ratios around 0.5 is indicated as delayed (light green), and ratios around 1 is indicated as halted (yellow). DBS, Deep Brain
Stimulation; SNc, Substantia Nigra pars compacta; STN, SubThalamic Nucleus; SCP, Single Contact Point; FCP, Four Contact Point; MCP, Multiple Contact Point.
4. DISCUSSION
4.1. Excitotoxicity Model
The goal of this work was to develop a model which investigates
the role of excitotoxicity in SNc cell loss, where excitotoxicity
was caused by STN and precipitated by energy deficiency. The
study suggests that excitotoxicity in SNc is initially driven by
an energy deficit which leads to an initial dopamine reduction
as a result of SNc cell loss. This initial dopamine reduction
causes disinhibition of STN which in turns leads to excitotoxic
damage due to excessive release of glutamate to its target nuclei
including SNc (Rodriguez et al., 1998). The excitotoxicity which
was driven by energy deficit, termed as “weak excitotoxicity,”
results in increased vulnerability of SNc neurons to even
physiological concentration of glutamate. The excitotoxicity
whichwas driven by overactive excitatory STNneurons termed as
“strong excitotoxicity” results in overactivation of glutamatergic
receptors on SNc neurons (Albin and Greenamyre, 1992). In
summary, it appears that the excitotoxic cause of SNc cell loss
in PD might be initiated by weak excitotoxicity mediated by
energy deficit, and followed by strong excitotoxicity, mediated by
disinhibited STN.
The results from the proposed model reinforce the role of
STN in regulating SNc cell loss (Hamani et al., 2004, 2017). The
model results show that although cell loss was observed, there
was no increased synchrony in the STN population which is a
pathological marker of the PD condition (Lintas et al., 2012).
Thus, the SNc cell loss and STN synchrony have a threshold-
like relation where there is an increased STN synchrony only
after substantial SNc cell loss. The initial SNc cell loss leads to
further activation of STN by disinhibition, which in turn further
activates SNc compensating for the dopamine loss, acting as a
pre-symptomatic compensatory mechanism (Bezard et al., 2003).
It was reported that the onset of PD symptoms occurs only after
there is more than 50% SNc cell loss (Bezard et al., 2001). This
was observed in our simulation results also where only at around
50–70% SNc cell loss there is in an increased STN synchrony.
As a result of substantial SNc cell loss, decreased dopamine
causes disinhibition of STN which in turn overactivates STN,
eventually producing a runaway effect that causes an unstoppable
SNc cell loss due to excitotoxic damage (Rodriguez et al., 1998).
The threshold-like behavior of SNc cell loss and STN synchrony
might also be facilitated by the inhibitory drive from GPe to
STN: the proliferation of GPe-STN synapses (Fan et al., 2012) also
acts as a presymptomatic compensatory mechanism. It was also
reported that lesioning of GPe caused progressive SNc cell loss by
increasing STN activity (Wright et al., 2002) and lesioning of STN
proved to be neuroprotective (Wright and Arbuthnott, 2007).
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To summarize, up to a point of stress threshold, SNc cells
can survive indefinitely; but if, for any reason, there is loss of
cells in SNc, and the SNc cell count falls below a threshold, from
that point onwards, the aforementioned runaway effect kicks in
leading to a progressive and irrevocable cell loss. Such cell loss is
strongly reminiscent of cell loss due to neurodegeneration.
4.2. Neuroprotective Strategies
A variety of conventional therapies are simulated in the
model to test their efficacy in slowing down or arresting
SNc cell loss. Among the current therapeutics, glutamate
inhibition, dopamine restoration, subthalamotomy and deep
brain stimulation showed superior neuroprotective effects in
the proposed model. Glutamate inhibition and subthalamotomy
were successful in delaying or arresting the SNc cell loss by
inhibiting the excitatory drive from STN to SNc (Lee et al.,
2003; Wallace et al., 2007; Austin et al., 2010), and in case of
dopamine restoration it is by replenishing the dopamine tone
to the STN which in turn restores inhibition on itself (Olanow
et al., 1998; Vaarmann et al., 2013), thereby diminishing STN-
mediated excitotoxicity in SNc. The neuroprotective effect of
glutamate inhibition, dopamine restoration and subthalamotomy
was dependent on the dosage of glutamate inhibitors, the
extent of dopamine restored and proportion of STN lesioned,
respectively. As the disease progresses, the effect of glutamate
inhibition on the rate of degeneration increased but in the
case of dopamine restoration and subthalamotomy, it was
decreased. In the late stages of disease progression, our
computational study indicates that the neuroprotective effect
of glutamate inhibition is more prominent than dopamine
restoration and subthalamotomy.
From our study, it can be said that subthalamotomy
mostly delays the SNc cell loss but very rarely halts it. This
phenomenon was not much evident in the late stages of
disease progression in the model which is consistent with the
standard clinical understanding that the neuroprotective
effect of subthalamotomy in advanced PD is not quite
successful (Guridi and Obeso, 2015). Early treatment
with subthalamotomy in PD can have a neuroprotective
effect (Guridi et al., 2016) a trend that was reflected in
our computational study. Another factor underlying the
neuroprotective effect of subthalamotomy during the early stage
of PD is the involvement of presymptomatic compensation
mechanisms (Bezard et al., 2003). One of the compensatory
mechanisms is the increased activity of STN before any
significant striatal dopamine loss which leads to excess
excitatory drive from STN to the remaining SNc cells to
restore the dopamine loss due to initial cell loss (Bezard
et al., 1999). This excess excitatory drive from STN eventually
leads to excitotoxicity in SNc neurons. To overcome this
excitotoxicity, subthalamotomy had to be applied very early
after diagnosis of PD to have any neuroprotective effect
(Guridi et al., 2016).
In our modeling study, we have explored various aspects
of DBS protocol from stimulus waveforms to stimulus
configurations and other DBS parameters. From the simulation
results, it can be suggested that biphasic stimulus waveform with
four-contact point stimulation configuration showed maximal
neuroprotective effect since biphasic stimulus guarantees charge-
balance in the stimulated neuronal tissue (Hofmann et al., 2011)
and DBS parameters were given in the Table 2.
It has been reported that long-term stimulation (DBS) of
STN results in the slowdown of the SNc cell loss in animal
models (Maesawa et al., 2004; Temel et al., 2006; Wallace
et al., 2007; Spieles-Engemann et al., 2010; Musacchio et al.,
2017), but the mechanism behind the neuroprotective benefits
of DBS is not elucidated. To understand the neuroprotective
effect of DBS in PD, we have investigated three prominent
hypotheses viz., excitation, inhibition and disruptive actions of
DBS (Chiken and Nambu, 2015). In the excitation hypothesis,
only DBS was applied which results in increased firing rate in
STN and leads to more excitatory drive to SNc which eventually
kills the SNc cells due to stress. Therefore, considering only
the excitation hypothesis cannot explain the neuroprotective
effect of DBS. Next, inhibition hypothesis was implemented
where antidromic activation of GPe result in the increased
inhibitory drive to STN (Mandali and Chakravarthy, 2016).
In this scenario also, the neuroprotective effect of DBS could
not be comprehensively explained. Finally, the disruptive
hypothesis was implemented by increasing the axonal and
synaptic failures in STN population during DBS therapy
(Rosenbaum et al., 2014). From simulation results, it was
observed that the progression of SNc cell loss kept on delaying
as the percentage of STN axonal and synaptic failure increased.
Therefore, it can be inferred that DBS blocks the propagation of
TABLE 2 | DBS parameter values obtained from the preliminary studies.
Parameter(s) SCP FCP MCP
DBS frequency (fDBS) in Hz 130 130 130
Monophasic pulse width (δDBS) in ms 100 100 100
Biphasic pulse width (δDBS) in ms 200 200 200
Monophasic DBS amplitude (ADBS) in pA 650 650 650
Biphasic DBS amplitude (ADBS) in pA 1,000 1,000 1,000
Spread of the current (σDBS) 5 2 0
Electrode contact point(s) (16, 16) (8, 8) (8, 24) (24, 8) (24, 24) Many
Hz, Hertz; ms, milliseconds; pA, picoamperes.
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pathological oscillations occurring in STN to other nuclei;
in other words DBS disrupts the information transfer
through the stimulation site, producing neuroprotection effect
in SNc (Ledonne et al., 2012).
4.3. Limitations and Future Directions
Though the model captures the exciting results of excitotoxicity,
it is not without limitations. The timescales which are represented
in the results of the proposed model are not realistic, as the
neurodegeneration which occurs over the years in PD was
exhibited in a few tens of seconds in the model. This limitation
is inevitable due to the practical challenges faced by computer
simulations since it is impractical to simulate the model for
months and years. The difficulty arises due to the fact that
the simulation must span widely separated time scales - sub-
millisecond time scales to describe spiking activity and years to
describe neurodegenerative processes.
The major inputs to the SNc neurons come from the striatum
which was not included in the model. As our objective was
to investigate the extent of STN-mediated excitotoxicity in
SNc, we avoided any other structures which can influence this
phenomenon at present.
In the proposed model, the variability of stress threshold,
which is analogous to an apoptotic threshold (that can be broadly
associated with the available energy represented as (ATP/ADP)
ratio), is sensitive enough to alter the model results is a constant
parameter. In order to achieve variability in this parameter,
astrocytic and vascular network-level models can be introduced.
With the astrocyte layer introduced, the effect of astrocytes on the
therapeutic effect of DBS can be explored (Fenoy et al., 2014).
In the future, we plan to simulate the SNc activity using
a detailed biophysical model to study the dynamics at the
molecular level and also to investigate the cellular pathways
related to PD pathology. We would like to include Spike-timing-
dependent plasticity (STDP) learning in STN population for the
long-term effect of DBS (Ebert et al., 2014).
Our hypothesis behind this whole study is to understand the
pathogenesis of PD as cellular energy deficiency in SNc as a cause.
As Wellstead and Cloutier pointed out (Wellstead and Cloutier,
2011), PD should be understood by placing the failure of brain
energy delivery mechanisms in the center as a core pathological
process, with other manifestations of pathology as deriving from
that core process (see the Figure 12 in Wellstead, 2010).
CODE ACCESSIBILITY
The code of the proposed excitotoxicity model is
available on ModelDB server (McDougal et al., 2017),
and access code will be provided on request.
(https://senselab.med.yale.edu/modeldb/enterCode.cshtml?
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